Beta Thalassemia Major Clinical Trial
Official title:
Effect of Spirulina on Serum Hyaluronic Acid as a Marker for Liver Fibrosis in Beta Thalassemic Children With Hepatitis C
Thalassemics can develop liver fibrosis because of iron overload and hepatitis C infection. The latter is the main risk factor for liver fibrosis in transfusion dependent thalassemics. Excess liver iron is clearly recognized as a co factor for the development of advanced fibrosis in patients with hepatitis virus C infection. Hyaluronic acid serum levels correlate with histological stages of liver fibrosis in hepatitis C patients, so it has a good diagnostic accuracy as a non invasive assessment of fibrosis and cirrhosis.there is evidence that suggests Spirulina may help to protect against liver damage, cirrhosis and liver failure in those with chronic liver disease.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT03276455 -
Gene Therapy for Beta-Thalassemia Major Using Autologous Hematopoietic Stem Cell Genetically Modified
|
Phase 1/Phase 2 | |
Completed |
NCT02674607 -
the Potential Immunomodulatory Effects of Spirulina on Thalassemic Children
|
N/A | |
Terminated |
NCT01571635 -
Study to Determine the Safety and Tolerability of Sotatercept (ACE-011) in Adults With Beta( β)- Thalassemia.
|
Phase 2 | |
Completed |
NCT04092205 -
Phase 2a Pilot Study of NBMI Treatment in Patients With Beta Thalassemia Major, Requiring Iron Chelation
|
Phase 2 | |
Completed |
NCT02744560 -
Effect of Spirulina on Liver Iron Concentration in Beta Thalassemic Children With Hepatitis C
|
N/A | |
Recruiting |
NCT06466304 -
Inspiratory Muscle Training in Children With Beta Thalasemia
|
N/A | |
Recruiting |
NCT04353986 -
PK of SOF/LED in HCV - Infected Adolescents With Haematological Disorders
|
Phase 3 | |
Not yet recruiting |
NCT02173951 -
An Algorithm to Start Iron Chelation in Minimally Transfused Young Beta-thalassemia Major Patients
|
Phase 2/Phase 3 | |
Completed |
NCT03947632 -
Anthropometric Measurements in Children Having Transfusion-dependent Beta Thalassemia
|
||
Withdrawn |
NCT04776850 -
Pre-transplant Immunosuppression and Donor Stem Cell Transplant for the Treatment of Severe Hemoglobinopathies
|
Early Phase 1 | |
Completed |
NCT02744105 -
Effect of Spirulina on Liver Fibrosis by Transient Elastography in Beta Thalassemic Children With Hepatitis C
|
N/A | |
Active, not recruiting |
NCT03101423 -
Monitoring of Chimerism After Transplantation in Patients With β Thalassemia Major and the Treatment Strategies for the Reduction of Chimerism
|
N/A | |
Completed |
NCT02671695 -
Effect of Spirulina Compared to Amlodipine on Cardiac Iron Overload in Children With Beta Thalassemia
|
N/A | |
Completed |
NCT00658385 -
Assess the Feasibility and Safety of Granulocyte Colony Stimulating Factor (GCSF) Mobilization of CD34+ Hematopoietic Progenitor Cells in Patients With Betathalassemia Major
|
N/A |